SPOTLIGHT: Encysive losses mount

Encysive losses mount
Shares of Encysive Pharmaceuticals took a hit in premarket trading after the company announced bigger losses than the numbers predicted by analysts. Much of the red ink was spilled in preparing for the European launch of its hypertension drug Thelin. Report